Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
02/2004
02/17/2004US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter
02/17/2004US6693190 Tetraazacyclododecane macrocycle derivatives including metal complexes; magnetic resonance imaging agents
02/17/2004US6693156 Simply and efficiently synthesized materials with varied substitution for tailored polymer properties
02/17/2004US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia
02/17/2004US6693117 Compounds with analgesic effect
02/17/2004US6692758 Administering orally, parenterally or externally effective amount of methanebisphosphonic acid derivative to stabilize implant or inhibit interstitial tissue proliferation
02/17/2004US6692742 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
02/12/2004WO2004013218A1 Antistatic agents and polymer compositions derived therefrom
02/12/2004WO2004013139A2 Process for preparing 7-azaindoles
02/12/2004WO2003099435A3 Catalyst and process for the cyanation of aldehydes
02/12/2004WO2003030151A3 Lubricant for magnetic recording medium and use thereof
02/12/2004WO2003029137A3 Derivatization and solubilization of insoluble classes of fullerenes
02/12/2004WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
02/12/2004US20040030200 Alcohol mixtures having 13 and 15 carbon atoms and the use thereof in the preparation of surface-active substances
02/12/2004US20040030105 Improved methods for synthesis of phosphinothiol reagents and novel protected reagents for use in peptide ligation
02/12/2004US20040030072 Using coordination catalyst
02/12/2004US20040030069 Coordination compounds and their use for the polymerization of olefins
02/12/2004US20040030015 Antistatic agents and polymer compositions derived therefrom
02/12/2004US20040029939 Inhibitors of IMPDH enzyme
02/12/2004US20040029897 Frangible compounds for pathogen inactivation
02/12/2004US20040029861 Using compound containing pyridine ring
02/12/2004US20040029851 Therapy for oxidation stresses; complex of drug and enzyme mimetics
02/12/2004US20040029838 Anticancer agents
02/12/2004US20040029836 Bactericides; antibiotic resistance
02/12/2004US20040029723 Novel aminophosphonium compounds
02/12/2004US20040029720 Supported group 8-10 transition metal olefin polymerization catalysts
02/12/2004US20040029367 Br2SbCH3 a solid source ion implant and CVD precursor
02/12/2004US20040028611 Diagnosis of anticholesterol agents; cardiovascular disorders; in situ detection of apatite
02/12/2004US20040026671 Phosphorus containing materials, their preparation and use
02/12/2004CA2397684A1 Mitochondrially targeted antioxidants
02/11/2004EP1388565A1 Near infrared ray-absorbing synthetic resin composition
02/11/2004EP1388546A2 Use of ionic compounds having a delocalised anionic charge as catalyst components
02/11/2004EP1387891A2 Compounds and methods for inhibiting axillary malodour
02/11/2004EP1387847A2 Enantiomers of unsaturated alkyllysophosphonocholines and use as anti-neoplastics
02/11/2004EP1387841A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides
02/11/2004EP1282628B1 N-(2-pyrimidinyl)(thio)phosphoric triamides, method for producing the same, and the use thereof as agents for regulating or inhibiting enzymatic urea hydrolysis
02/11/2004EP1165491B1 Lta4 hydrolase inhibitors
02/11/2004EP1003754B1 Method of manufacturing phosphine compound
02/11/2004EP0862575B1 Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
02/11/2004CN1474825A Process for preparation of 2-carboxy-alkyl (aryl) phosphonic acids and anhydrides
02/11/2004CN1474817A Improved method for water soluble azole compounds
02/11/2004CN1474704A Multipurpose packages for sterilized products or products to be sterilised
02/11/2004CN1474689A CDC25 phosphatase inhibitors
02/11/2004CN1137886C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
02/10/2004US6689915 As catalysts for use in asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds
02/10/2004US6689804 Imidazo-imidazole
02/05/2004WO2004011481A1 Phosmidosine derivative and process for producing the same
02/05/2004WO2004011475A1 Polyaminomethylenephos phonate derivatives
02/05/2004WO2004011423A2 Structural carotenoid analogs for the inhibition and amelioration of disease
02/05/2004WO2004010949A2 Compounds active in spinigosine 1-phosphate signaling
02/05/2004WO2004010846A2 Design and synthesis of renal dipeptidase inhibitors
02/05/2004WO2004010842A2 Lipophilic electrophoretic probes
02/05/2004WO2003074475A3 Substituted aryl ketones
02/05/2004WO2003051348A3 Composition, synthesis and therapeutic applications of polyamines
02/05/2004US20040024258 By reaction with carbon monoxide and a coreactant in the presence of a catalyst system comprising a source of platinum group metal cations and a certain bidentate diphosphine composition
02/05/2004US20040024255 Environmentally friendly and is suitable for printed circuit board and semiconductor encapsulation applications
02/05/2004US20040024247 By reaction with carbon monoxide and a coreactant in the presence of a catalyst system comprising a source of platinum group metal cations and a certain bidentate diphosphine composition
02/05/2004US20040024245 Method for isolating pharmaceutically exploitable etidronate disodium
02/05/2004US20040024227 For continuous processing
02/05/2004US20040024150 Amino acid complexes and the use thereof in producing olefin polymers
02/05/2004US20040024057 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications
02/05/2004US20040023943 A cephem compound (particularly its crystal) represented by the formula (I), wherein X is CH3COOH, CH3CH2COOH or CH3CN, and n is 0 to 5, is useful as an antibacterial agent (particularly anti-MRSA agent) and shows superior quality such
02/05/2004US20040023927 Bicyclic imidazo-5-yl-amine derivatives
02/05/2004US20040023920 The use of adenosine-5'-triphosphate-2',3'-dialdehyde (oATP) as a medicament useful for the treatment of inflammatory conditions
02/05/2004US20040023304 Functionalized with a hydrophilic linker which contain a tethering group for binding to a surface; can be used for applications such as model systems for examining biological membranes, screening methods, sensors, bioelectronic devices
02/05/2004US20040023092 Exhibit extensive delocalization of the negative charge and good activity in polymerization or in copolymerization and allow the preparation of macromolecules possessing dissociated and stable ionic functional groups
02/05/2004US20040023062 An anode, a layer of a hole transporting material which emits light in the blue spectrum, a layer of an organo metallic complex and a cathode; emits white light
02/05/2004US20040022843 Lipophilic electrophoretic probes
02/05/2004DE10234326B3 Novel acrylic ester phosphonic acids for use in dental materials e.g. cements or adhesives comprise improved hydrolytic stability
02/05/2004DE10216736A1 Flammschutzmittel für Polymere enthaltend eine Mischung aus zwei verschiedenen Arylphosphaten, deren Herstellung und deren Verwendung Flame retardants for polymers comprising a mixture of two different aryl phosphates, their preparation and their use
02/05/2004CA2533587A1 Compounds active in sphingosine 1-phosphate signaling
02/05/2004CA2495167A1 Structural carotenoid analogs for the inhibition and amelioration of disease
02/05/2004CA2493671A1 Lipophilic electrophoretic probes
02/04/2004EP1386946A1 4,7-dichlororhodamine dyes useful as molecular probes
02/04/2004EP1386905A1 Stable solution of reduced coenzyme q
02/04/2004EP1386884A1 Electron acceptor compositions on polymer templates and catalytic production of hydrogen peroxide
02/04/2004EP1385996A2 Charge tags and separation of nucleic acid molecules
02/04/2004EP1385855A1 Process to prepare a multidentate phosphine compound
02/04/2004EP1385853A2 Beta-lactamase substrates having phenolic ethers
02/04/2004EP1385846A2 Synthesis of pancratistatin prodrugs
02/04/2004EP1385524A1 Pyrazolopyrimidines as therapeutic agents
02/04/2004EP1385379A1 Insecticide and method of controlling insects
02/04/2004EP1282629B1 Bidentate ligands useful in catalyst sytems
02/04/2004EP1213962B1 Pesticide formulations containing phosphate ester surfactant and alkoxylated lignosulfonate
02/04/2004EP1127041B1 Process for manufacturing alkanes
02/04/2004EP0937096B1 Method of mass spectrometry analysis
02/04/2004EP0850105B1 A compound which is usable in a catalytic composition
02/04/2004EP0730404B1 Amphiphilic imidazolinium derivatives
02/04/2004EP0642507B1 Transition state analogues of cocaine, their use for producing catalytic antibodies against cocaine and use of the same in diagnosis and therapy
02/04/2004CN1472215A Synthesis of product prepared from imidazole acted with halogenated acetate ethyl ester
02/04/2004CN1137144C Polymerization with living characteristics
02/03/2004US6686500 By carbonylation in the presence of an iridium catalyst and methyl iodide co-catalyst
02/03/2004US6686488 Constrained geometry addition polymerization catalysts
02/03/2004US6686477 Multistep chemical synthesis, including asymmetric hydrogenation of a lactam-enamide to produce an intermediate that can be used to make unspecified pharmaceuticals
02/03/2004US6686458 Such as 4',5'-bis(2-arsa-1,3-dithiolan-2-yl)fluorescein) for labelling of polypeptides; genetic engineering
02/03/2004US6686344 Organic-arsonic compounds
02/03/2004US6685914 Contrast agents in x-ray imaging, magnetic resonance imaging (mri) and radiopharmaceuticals, heavy metal detoxification; 1,4,8,11-tetraaza-6,13-phosphacyclotetradecane compound with phosphinic bridges
02/03/2004US6684525 Surfactants containing phosphate group attached to fluorohydrocarabon, or hybrid with phosphate group attached to hydrocarbon exhibit solubility in carbon dioxide
01/2004
01/29/2004WO2004009878A2 Electrochemical processing cell
01/29/2004WO2004009784A2 Novel inhibitors of kinases